News from cryolife, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 09, 2021, 16:05 ET CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will ...

Nov 04, 2021, 16:05 ET CryoLife Reports Third Quarter 2021 Financial Results

Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third...

Oct 20, 2021, 16:10 ET CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021...

Sep 22, 2021, 16:25 ET Anthony Semedo Joins CryoLife Board of Directors

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony...

Aug 31, 2021, 16:25 ET CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...

Aug 02, 2021, 16:30 ET CryoLife to Participate in Upcoming Virtual Investor Conferences

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two ...

Jul 29, 2021, 16:05 ET CryoLife Reports Second Quarter 2021 Financial Results

Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second ...

Jul 29, 2021, 08:00 ET CryoLife Announces Sale of PerClot to Baxter

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale...

Jul 15, 2021, 16:25 ET CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021...

May 18, 2021, 08:35 ET CryoLife to Participate in the UBS Global Healthcare Virtual Conference

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...

Apr 29, 2021, 16:05 ET CryoLife Reports First Quarter 2021 Financial Results

First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first...

Apr 15, 2021, 08:35 ET CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021...

Apr 07, 2021, 08:35 ET CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...

Mar 09, 2021, 08:35 ET CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...

Feb 11, 2021, 16:05 ET CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results

Fourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2020 versus $69.7 million in the fourth ...

Jan 28, 2021, 08:30 ET CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full...

Nov 19, 2020, 08:30 ET CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for ...

Nov 04, 2020, 16:05 ET CryoLife Reports Third Quarter 2020 Financial Results

Third Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third quarter 2020 versus $67.9 million in the third...

Oct 21, 2020, 08:04 ET CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter...

Sep 08, 2020, 16:47 ET CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...

Sep 02, 2020, 16:02 ET CryoLife Acquires Ascyrus Medical

CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has...

Aug 06, 2020, 08:35 ET CryoLife to Participate in Upcoming Virtual Investor Conferences

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two ...

Jul 30, 2020, 16:05 ET CryoLife Reports Second Quarter 2020 Financial Results

Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second ...

Jul 21, 2020, 17:00 ET CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter...

Jun 19, 2020, 07:05 ET CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering

CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced...